Affiliation:
1. Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA.
Abstract
In recent decades, a proprietary culture, which wrongly posits that all intellectual property must be restricted, has spread across the pharmaceutical industry and threatens to stall the engine that has yielded many valuable treatments.
Publisher
American Association for the Advancement of Science (AAAS)
Reference20 articles.
1. J. R. Hollingsworth in Innovation Science and Institutional change J. Hage M. T. H. Meeus Eds. (Oxford Univ. Press New York 2006) pp. 423–442.
2. F. M. Scherer Pharmaceutical Innovation (Working Paper No. 07-19 AEI-Brookings Joint Center 2007).
3. Eli Lilly’s PD 2 Initiative: https://www.pd2.lilly.com/pd2Web.
4. Innocentive http://www.innocentive.com.
5. The Major Role of Clinicians in the Discovery of Off-Label Drug Therapies
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献